Utah Medical Products (NASDAQ: UTMD) revenue
Utah Medical Products reported revenue of $38.5m for fiscal 2025, 5.8% less than in fiscal 2024 ($40.9m). Since fiscal 2016 its revenue has fallen by 2.0%, an average decline of 0.2% a year.
Utah Medical Products's revenue has fallen for 3 years in a row, and its best year of the last 10 was fiscal 2022. The biggest drop was in fiscal 2024, −18.6%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $38.5m | −5.8% | $11.4m | 29.6% |
| 2024 | $40.9m | −18.6% | $13.6m | 33.2% |
| 2023 | $50.2m | −3.9% | $16.8m | 33.4% |
| 2022 | $52.3m | +6.6% | $19.8m | 37.9% |
| 2021 | $49.1m | +16.3% | $18.9m | 38.5% |
| 2020 | $42.2m | −10.1% | $13.7m | 32.5% |
| 2019 | $46.9m | +11.7% | $17.6m | 37.6% |
| 2018 | $42.0m | +1.4% | $18.7m | 44.5% |
| 2017 | $41.4m | +5.4% | $19.0m | 45.9% |
| 2016 | $39.3m | — | $16.2m | 41.2% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Utah Medical Products revenue compared with its sector
By revenue for its latest fiscal year, Utah Medical Products ranks 341st of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Utah Medical Products, −5.8%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 339th | Voyager Therapeutics | $40.4m | −49.5% |
| 340th | Kymera Therapeutics | $39.2m | −16.7% |
| 341st | Utah Medical Products | $38.5m | −5.8% |
| 342nd | ClearPoint Neuro | $37.0m | 17.8% |
| 343rd | C4 Therapeutics | $35.9m | 1.0% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Utah Medical Products
- How much revenue did Utah Medical Products make in fiscal 2025?
- Utah Medical Products reported revenue of $38.5m for fiscal 2025, compared with $40.9m in fiscal 2024.
- How much has the revenue of Utah Medical Products fallen?
- Between fiscal 2016 and fiscal 2025 it went from $39.3m to $38.5m: 2.0% less, an average decline of 0.2% a year.
- What was the best year for revenue at Utah Medical Products?
- Of its last 10 fiscal years, fiscal 2022, with $52.3m.
- Where does Utah Medical Products rank in its sector by revenue?
- It ranks 341st of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Utah Medical Products come from?
- From the annual report (Form 10-K) that Utah Medical Products files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Utah Medical Products files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Utah Medical Products: the Utah Medical Products page · annual accounts · net income · dividends paid · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.